Table of Contents
1 Industry Outlook 8
1.1 Market Overview 8
1.2 Total addressable market 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 15
3.1 Market Definition - Infoholic Research 15
3.2 Advantages of blood glucose monitoring systems 15
3.3 Segmented Addressable Market (SAM) 15
3.4 Trends of the blood glucose monitoring systems market 15
3.5 Related Markets 17
3.5.1 Insulin pump 17
3.5.2 Smart insulin pen 17
3.5.3 Insulin Syringes 17
4 Market Outlook 18
4.1 Evolution of Blood Glucose Monitoring 18
4.2 Market segmentation 18
4.3 PEST Analysis 18
4.4 Porter 5(Five) Forces 19
5 Market Characteristics 21
5.1 DRO - Global Blood Glucose Monitoring Systems Market Dynamics 21
5.1.1 Drivers 21
5.1.1.1 Increasing incidence of diabetes across various geographies 21
5.1.1.2 Increasing number of product launch and approvals 22
5.1.1.3 Huge surge in the aging population 22
5.1.2 Opportunities 23
5.1.2.1 New collaboration and funding to develop new devices 23
5.1.2.2 Growing patient awareness 23
5.1.3 Restraints 24
5.1.3.1 High cost and inadequate reimbursement 24
5.1.3.2 Product recalls 24
5.2 DRO - Impact Analysis 24
5.3 Key Stakeholders 25
6 Products: Market Size & Analysis 27
6.1 Overview 27
6.2 Self-monitoring Blood Glucose Systems 28
6.3 Continuous Glucose Monitoring Systems 29
7 Application: Market Size & Analysis 31
7.1 Overview 31
7.2 Type 1 Diabetes 32
7.3 Type 2 Diabetes 32
7.4 Gestational Diabetes 33
8 End-User: Market Size & Analysis 34
8.1 Overview 34
8.2 Hospitals 35
8.3 Homecare 35
8.4 Private clinics 35
8.5 Others 36
9 Regions: Market Size and Analysis 37
9.1 Overview 37
9.2 North America 38
9.3 Europe 40
9.4 Asia Pacific 41
9.5 Rest of the World 43
10 Competitive Landscape 45
10.1 Overview 45
11 Vendor Profiles 48
11.1 Medtronic plc 48
11.1.1 Overview 48
11.1.2 Medtronic plc: Recent Developments 49
11.1.3 Business Units 56
11.1.4 Geographic Revenue 57
11.1.5 Business Focus 58
11.1.6 SWOT Analysis 58
11.1.7 Business Strategies 59
11.2 Abbott Laboratories 60
11.2.1 Overview 60
11.2.2 Abbott Laboratories: Recent Developments 61
11.2.3 Business Units 63
11.2.4 Geographic Presence 65
11.2.5 Business Focus 65
11.2.6 SWOT Analysis 66
11.2.7 Business Strategies 66
11.3 Johnson and Johnson 67
11.3.1 Overview 67
11.3.2 Business Units 71
11.3.3 Geographic Revenue 72
11.3.4 Business Focus 73
11.3.5 SWOT Analysis 74
11.3.6 Business Strategies 74
11.4 F.Hoffmann-La Roche Ltd. 75
11.4.1 Overview 75
11.4.2 Business Unit 78
11.4.3 Geographic Presence 78
11.4.4 Business Focus 79
11.4.5 SWOT Analysis 79
11.4.6 Business Strategy 80
12 Companies to Watch for 81
12.1 Dexcom 81
12.1.1 Overview 81
12.2 PHC Holdings Corporation 82
12.2.1 Overview 82
12.3 Ypsomed Holding 85
12.3.1 Overview 85
12.4 B. Braun Melsungen AG 86
12.4.1 Overview 86
12.5 Trividia Health' Inc. 88
12.5.1 Overview 88
12.6 Acon Laboratories 89
12.6.1 Overview 89
12.7 Sanofi S.A. 90
12.7.1 Overview 90
12.8 Arkray' Inc. 93
12.8.1 Overview 93
12.9 Nova Biomedical Corporation 94
12.9.1 Overview 94
12.10 Prodigy Diabetes Care' LLC 95
12.10.1 Overview 95
12.11 Terumo Medical Corporation 96
12.11.1 Overview 96
Annexure 99
? Acronyms 99